X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (868) 868
Publication (87) 87
Book Chapter (4) 4
Book Review (4) 4
Dissertation (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (617) 617
male (465) 465
female (460) 460
index medicus (397) 397
leukopenia (330) 330
adult (273) 273
middle aged (267) 267
leukopenia - chemically induced (214) 214
animals (207) 207
aged (190) 190
leukopenia - genetics (170) 170
oncology (161) 161
hematology (145) 145
adolescent (129) 129
mice (124) 124
neutropenia (115) 115
patients (112) 112
chemotherapy (111) 111
child (106) 106
cancer (104) 104
toxicity (103) 103
immunology (102) 102
genotype (99) 99
research (99) 99
thrombocytopenia (98) 98
research article (93) 93
leukopenia - etiology (87) 87
risk factors (84) 84
medicine (80) 80
pharmacology & pharmacy (80) 80
treatment outcome (80) 80
analysis (76) 76
leukocyte count (76) 76
child, preschool (75) 75
young adult (73) 73
therapy (71) 71
azathioprine (69) 69
care and treatment (67) 67
mutation (65) 65
retrospective studies (65) 65
leukopenia - pathology (64) 64
health aspects (63) 63
multidisciplinary sciences (62) 62
genetic aspects (61) 61
science (61) 61
anemia (60) 60
pharmacogenetics (60) 60
aged, 80 and over (59) 59
infectious diseases (58) 58
leukopenia - immunology (58) 58
lymphocytes (58) 58
blood (57) 57
leucopenia (57) 57
leukopenia - blood (57) 57
infant (55) 55
survival (53) 53
azathioprine - adverse effects (52) 52
bone marrow (50) 50
pediatrics (50) 50
polymorphism, genetic (50) 50
antineoplastic combined chemotherapy protocols - therapeutic use (49) 49
leukopenia - complications (49) 49
methyltransferases - genetics (49) 49
infections (48) 48
expression (47) 47
pharmacokinetics (47) 47
6-mercaptopurine (46) 46
abridged index medicus (46) 46
phenotype (46) 46
infection (45) 45
antineoplastic combined chemotherapy protocols - adverse effects (44) 44
children (44) 44
gastroenterology & hepatology (44) 44
mice, inbred c57bl (44) 44
drug therapy (42) 42
prognosis (41) 41
studies (41) 41
inflammatory-bowel-disease (40) 40
disease models, animal (39) 39
immunosuppressive agents - adverse effects (39) 39
mice, knockout (39) 39
risk (39) 39
inflammatory bowel disease (38) 38
diagnosis (37) 37
disease (37) 37
physiological aspects (37) 37
thrombocytopenia - chemically induced (37) 37
time factors (37) 37
transplantation (37) 37
article (36) 36
dose-response relationship, drug (36) 36
leukemia (36) 36
leukopenia - diagnosis (36) 36
cancer therapies (35) 35
clinical trials (35) 35
complications and side effects (35) 35
medicine & public health (35) 35
medicine and health sciences (35) 35
viruses (35) 35
drug administration schedule (34) 34
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (822) 822
German (9) 9
French (8) 8
Russian (8) 8
Chinese (7) 7
Spanish (6) 6
Korean (4) 4
Polish (4) 4
Hebrew (2) 2
Japanese (2) 2
Czech (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS Genetics, ISSN 1553-7390, 01/2009, Volume 5, Issue 1, p. e1000360
Journal Article
Blood, ISSN 0006-4971, 02/2010, Volume 115, Issue 8, pp. 1519 - 1529
Journal Article
Pediatrics, ISSN 0031-4005, 02/2013, Volume 131, Issue 2, pp. e629 - e634
Folate and vitamin B-12 metabolism are essential for de novo purine synthesis, and several defects in these pathways have been associated with... 
Cobalamin | Megaloblast | Hemolytic uremic syndrome | Folate | Immunodeficiency | folate | DEFECTS | cobalamin | GENE | megaloblast | TRANSCOBALAMIN-II DEFICIENCY | ABNORMALITIES | PEDIATRICS | immunodeficiency | PATIENT | hemolytic uremic syndrome | Peripheral Nervous System Diseases - diagnosis | Leukopenia - diagnosis | Lipid Metabolism, Inborn Errors - genetics | Pneumonia, Pneumocystis - diagnosis | Humans | 3-Hydroxyacyl CoA Dehydrogenases - genetics | Vitamin B 12 - therapeutic use | DNA Mutational Analysis | Sulfadoxine - therapeutic use | Cardiomyopathies - diagnosis | Infant, Newborn | Cardiomyopathies - drug therapy | Mitochondrial Myopathies | Retinitis Pigmentosa - drug therapy | Trimethoprim - therapeutic use | Combined Modality Therapy | Bone Marrow Examination | Sequence Analysis, DNA | Retinitis Pigmentosa - diagnosis | Severe Combined Immunodeficiency - genetics | Pneumonia, Pneumocystis - genetics | Immunization, Passive | Leukopenia - drug therapy | Genetic Carrier Screening | Peripheral Nervous System Diseases - drug therapy | Mitochondrial Trifunctional Protein - deficiency | Anemia, Megaloblastic - genetics | Minor Histocompatibility Antigens | Lipid Metabolism, Inborn Errors - drug therapy | Leukopenia - genetics | Infant | Rhabdomyolysis | Cardiomyopathies - genetics | Anemia, Megaloblastic - diagnosis | Female | Drug Therapy, Combination | Peripheral Nervous System Diseases - genetics | Methylenetetrahydrofolate Dehydrogenase (NADP) - genetics | Hydroxocobalamin - therapeutic use | Pneumonia, Pneumocystis - drug therapy | Severe Combined Immunodeficiency - diagnosis | Lipid Metabolism, Inborn Errors - diagnosis | Severe Combined Immunodeficiency - drug therapy | Retinitis Pigmentosa - genetics | Opportunistic Infections - genetics | Opportunistic Infections - diagnosis | Exome - genetics | Opportunistic Infections - drug therapy | Anemia, Megaloblastic - drug therapy | 3-Hydroxyacyl CoA Dehydrogenases - deficiency | Drug Combinations | Nervous System Diseases | Care and treatment | Gene mutations | Research | Nucleotide sequencing | Diagnosis | Vitamin B12 | Hemolytic-uremic syndrome | DNA sequencing | Pediatrics | Immunology | Vitamin B | Genetics | Mutation | Drug therapy | Metabolism
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 13, pp. 2131 - 2138
Journal Article
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 138, Issue 6, pp. 1681 - 1689.e8
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2018, Volume 13, Issue 3, p. e0194400
Journal Article
Annals of Oncology, ISSN 0923-7534, 04/2012, Volume 23, Issue 4, pp. 961 - 967
Background: Platinum-based therapy is widely used in the treatment of malignant mesothelioma (MM); however, the efficacy and toxicity of platinum agents vary... 
Malignant mesothelioma | Pharmacogenetics | Glutathione S-transferases | DNA repair polymorphisms | Platinum | SURVIVAL | GENETIC POLYMORPHISMS | PLEURAL MESOTHELIOMA | malignant mesothelioma | PHASE-II | platinum | CISPLATIN | ONCOLOGY | DNA | COMBINATION CHEMOTHERAPY | GLUTATHIONE-S-TRANSFERASE | REPAIR GENES | pharmacogenetics | EPITHELIAL OVARIAN | glutathione S-transferases | Haplotypes | Endonucleases - genetics | Nausea - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Leukopenia - genetics | Male | Mesothelioma - mortality | DNA Repair - genetics | Cisplatin - administration & dosage | Thrombocytopenia - genetics | Glutathione Transferase - genetics | Alopecia - genetics | Leukopenia - chemically induced | Aged, 80 and over | Adult | Female | Xeroderma Pigmentosum Group D Protein - genetics | Genetic Association Studies | Nausea - genetics | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Mesothelioma - genetics | Thrombocytopenia - chemically induced | DNA-Binding Proteins - genetics | Sequence Analysis, DNA | Mesothelioma - drug therapy | Polymorphism, Genetic | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Alopecia - chemically induced | Aged | Index Medicus
Journal Article
Journal Article